|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 487/04 | (2006.01) |
| A61K 31/5025 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 43/00 | (2006.01) |
| (11) | Number of the document | 3458456 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17726442.1 |
| Date of filing the European patent application | 2017-05-18 | |
| (97) | Date of publication of the European application | 2019-03-27 |
| (45) | Date of publication and mention of the grant of the patent | 2020-11-25 |
| (46) | Date of publication of the claims translation | 2021-02-25 |
| (86) | Number | PCT/US2017/033257 |
| Date | 2017-05-18 |
| (87) | Number | WO 2017/201241 |
| Date | 2017-11-23 |
| (30) | Number | Date | Country code |
| 201662338359 P | 2016-05-18 | US |
| (72) |
REYNOLDS, Mark, US
EARY, Charles Todd, US
SPENCER, Stacey, US
JUENGST, Derrick, US
HACHE, Bruno, US
JIANG, Yutong, US
HAAS, Julia, US
ANDREWS, Steven W., US
|
| (73) |
Array Biopharma Inc.,
3200 Walnut Street, Boulder, CO 80301,
US
Loxo Oncology, Inc., 281 Tresser Boulevard 9th Floor, Stamford, Connecticut 06901, US |
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | (S)-N-(5-((R)-2-(2,5-difluorfenil)pirolidin-1-il)pirazolo[1,5-a]pirimidin-3-il)-3-hidroksipirolidin-1-karboksamido gavimas |
| PREPARATION OF (S)-N-(5-((R)-2-(2,5-DIFLUOROPHENYL)PYRROLIDIN-1-YL)PYRAZOLO[1,5-A]PYRIMIDIN-3-YL)-3-HYDROXYPYRROLIDINE-1-CARBOXAMIDE |
| Payment date | Validity (years) | Amount | |
| 2026-04-20 | 10 | 231.00 EUR |
| 2027-05-18 |